REAL-WORLD COST OF TREATING INADEQUATE RESPONDERS TO ANTI-TUMOUR NECROSIS FACTOR THERAPY

被引：0
|
作者：
Thomson, E. [1 ]
Nadkarni, A. [2 ]
Brouillette, M. [1 ]
Johnston, S. [1 ]
机构：
[1] Truven Hlth Analyt, Bethesda, MD USA
[2] Bristol Myers Squibb, Plainsboro, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.1737
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0414
引用
收藏
页码：1032 / 1032
页数：1
相关论文
共 50 条
  • [1] Real-World Cost of Treating Inadequate Responders to Anti-Tumor Necrosis Factor Therapy
    Nadkarni, A.
    Brouillette, M.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Indicators of inadequate response to anti-tumour necrosis factor therapies in patients with ulcerative colitis from real-world practice settings
    Hatoum, H. T.
    Patel, H.
    Lin, S. -J.
    Mody, R.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S148 - S148
  • [3] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Borman, Pinar
    Ayhan, Figen
    Ceceli, Esma
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (12) : 1689 - 1690
  • [4] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Pinar Borman
    Figen Ayhan
    Esma Ceceli
    Rheumatology International, 2010, 30 : 1689 - 1690
  • [5] Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy
    R Russo
    M Katsicas
    Pediatric Rheumatology, 9 (Suppl 1)
  • [6] Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy
    Gao, Y.
    Jin, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (01) : E46 - E48
  • [7] Anti-tumour necrosis factor (TNF)-α therapy (etanercept)
    Maya Buch
    Arthritis Research & Therapy, 4 (1)
  • [8] Anti-tumour necrosis factor therapy in the West Midlands
    Bartram, D
    Sheeran, T
    Price, T
    Mulherin, D
    RHEUMATOLOGY, 2004, 43 (03) : 400 - 400
  • [9] Anti-tumour necrosis factor therapy in seronegative spondyloarthritis
    Swales, C
    Bowness, P
    CLINICAL MEDICINE, 2005, 5 (03) : 219 - 222
  • [10] ANTI-TUMOUR NECROSIS FACTOR COST-SAVING AUDIT
    Suresh, Resmy
    Kiely, Patrick
    RHEUMATOLOGY, 2017, 56 : 194 - 194
12345